NCT01163071View on ClinicalTrials.gov

A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

PHASE1TerminatedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 1, 2011

Primary Completion Date

September 23, 2011

Study Completion Date

September 23, 2011

Conditions

Advanced Solid Tumors

Interventions

DRUG

ABI-011

ABI-011

Trial Locations (2)

48201

Karmanos Cancer Center Institute, Detroit

78229

CTRC @ The Utah Health Science Center @ San Antonio, San Antonio

Sponsors

Lead Sponsor

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Celgene

INDUSTRY

NCT01163071 - A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas | Biotech Hunter | Biotech Hunter